- Home
- SDGR vs LIVN Comparison
SDGR vs LIVN Comparison
Compare SDGR & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDGR
- LIVN
- Stock Information
- Founded
- SDGR 1990
- LIVN 1987
- Country
- SDGR United States
- LIVN United Kingdom
- Employees
- SDGR N/A
- LIVN N/A
- Industry
- SDGR Biotechnology: Pharmaceutical Preparations
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SDGR Health Care
- LIVN Health Care
- Exchange
- SDGR Nasdaq
- LIVN Nasdaq
- Market Cap
- SDGR 1.8B
- LIVN 2.1B
- IPO Year
- SDGR 2020
- LIVN 1993
- Fundamental
- Price
- SDGR $23.91
- LIVN $44.06
- Analyst Decision
- SDGR Buy
- LIVN Buy
- Analyst Count
- SDGR 5
- LIVN 7
- Target Price
- SDGR $32.80
- LIVN $58.57
- AVG Volume (30 Days)
- SDGR 1.5M
- LIVN 882.2K
- Earning Date
- SDGR 05-07-2025
- LIVN 05-07-2025
- Dividend Yield
- SDGR N/A
- LIVN N/A
- EPS Growth
- SDGR N/A
- LIVN N/A
- EPS
- SDGR N/A
- LIVN N/A
- Revenue
- SDGR $230,492,000.00
- LIVN $1,275,380,000.00
- Revenue This Year
- SDGR $24.12
- LIVN $5.79
- Revenue Next Year
- SDGR $18.60
- LIVN $5.51
- P/E Ratio
- SDGR N/A
- LIVN N/A
- Revenue Growth
- SDGR 22.29
- LIVN 7.62
- 52 Week Low
- SDGR $16.60
- LIVN $32.48
- 52 Week High
- SDGR $28.47
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- SDGR 49.40
- LIVN 70.16
- Support Level
- SDGR $22.69
- LIVN $35.00
- Resistance Level
- SDGR $24.92
- LIVN $37.95
- Average True Range (ATR)
- SDGR 1.38
- LIVN 1.30
- MACD
- SDGR -0.33
- LIVN 1.06
- Stochastic Oscillator
- SDGR 26.64
- LIVN 91.36
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.